Piperacillin

CHEMBL702 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

517.6 g/mol

LogP

0.5

Phase

4

A broad-spectrum penicillin-type antibiotic used to treat serious bacterial infections including pneumonia, urinary tract infections, and skin infections, often combined with another medication called tazobactam to prevent bacterial resistance. It is typically given intravenously in hospital settings for severe infections.

분자량

517.6000 g/mol

LogP

0.50

TPSA

182.00 Å²

리핀스키 5의 법칙

통과

치료 영역

Pancreatic Cancer Cardiovascular Disease Age-Related Macular Degeneration Pain Management Asthma Chronic Obstructive Pulmonary Disease Epilepsy Migraine Schizophrenia Bipolar Disorder Generalized Anxiety Disorder Insomnia Infectious Disease Chronic Kidney Disease Deep Vein Thrombosis / Pulmonary Embolism Obesity Lymphoma Hypertension Chronic Pain Heart Failure Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O

InChI

InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1

Molecular Formula

C23H27N5O7S

HBD / HBA

3 / 8

회전 가능 결합

6

무거운 원자

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A broad-spectrum penicillin-type antibiotic used to treat serious bacterial infections including pneumonia, urinary tract infections, and skin infections, often combined with another medication called tazobactam to prevent bacterial resistance. It is typically given intravenously in hospital settings for severe infections.

Yes, Piperacillin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL702. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 43672. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Piperacillin PillFYI에서

구조

핵심 데이터

분자식: C23H27N5O7S
동의어: 5

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.